Laurie G. Hudson - Publications

Biomedical Sciences University of New Mexico, Albuquerque, NM, United States 
Biochemistry, Cell Biology, Pharmacy

72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Zhou X, Ding X, Shen J, Yang D, Hudson LG, Liu KJ. Peroxynitrite contributes to arsenic-induced PARP-1 inhibition through ROS/RNS generation. Toxicology and Applied Pharmacology. 114602. PMID 31152818 DOI: 10.1016/j.taap.2019.114602  0.44
2017 Ding X, Zhou X, Cooper KL, Huestis J, Hudson LG, Liu KJ. Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue. Toxicology and Applied Pharmacology. PMID 28552776 DOI: 10.1016/j.taap.2017.05.031  0.44
2016 Zhou X, Cooper KL, Huestis J, Xu H, Burchiel SW, Hudson LG, Liu KJ. S-nitrosation on zinc finger motif of PARP-1 as a mechanism of DNA repair inhibition by arsenite. Oncotarget. PMID 27741521 DOI: 10.18632/oncotarget.12613  0.44
2016 Xu H, McClain S, Medina S, Lauer FT, Douillet C, Liu KJ, Hudson LG, Stýblo M, Burchiel SW. Differential Sensitivities of Bone Marrow, Spleen and Thymus to Genotoxicity Induced By Environmentally Relevant Concentrations of Arsenite. Toxicology Letters. PMID 27659730 DOI: 10.1016/j.toxlet.2016.09.008  1
2016 Huestis J, Zhou X, Chen L, Feng C, Hudson LG, Liu KJ. Kinetics and thermodynamics of zinc(II) and arsenic(III) binding to XPA and PARP-1 zinc finger peptides. Journal of Inorganic Biochemistry. 163: 45-52. PMID 27521476 DOI: 10.1016/j.jinorgbio.2016.08.003  1
2016 Xu H, Lauer FT, Liu KJ, Hudson LG, Burchiel SW. Interactive Genotoxicity Induced by Environmentally Relevant Concentrations of Benzo(a)pyrene Metabolites and Arsenite in Mouse Thymus Cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 27503386 DOI: 10.1093/toxsci/kfw151  0.44
2016 Xu H, Lauer FT, Liu KJ, Hudson LG, Burchiel SW. Environmentally Relevant Concentrations of Arsenite and Monomethylarsonous Acid Inhibit IL-7/STAT5 Cytokine Signaling Pathways in Mouse CD3+CD4-CD8- Double Negative Thymus Cells. Toxicology Letters. PMID 26921788 DOI: 10.1016/j.toxlet.2016.02.014  0.44
2015 Cooper KL, Dashner EJ, Tsosie R, Cho YM, Lewis J, Hudson LG. Inhibition of poly(ADP-ribose)polymerase-1 and DNA repair by uranium. Toxicology and Applied Pharmacology. PMID 26627003 DOI: 10.1016/j.taap.2015.11.017  1
2015 Ezeh PC, Xu H, Lauer FT, Liu KJ, Hudson LG, Burchiel SW. Monomethylarsonous acid (MMA+3) Inhibits IL-7 Signaling in Mouse Pre-B Cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26518055 DOI: 10.1093/toxsci/kfv233  0.44
2015 Xu H, Zhou X, Wen X, Lauer FT, Liu KJ, Hudson LG, Aleksunes LM, Burchiel SW. Environmentally-Relevant Concentrations of Arsenite Induce Dose-Dependent Differential Genotoxicity Through Poly(ADP-ribose) Polymerase (PARP) Inhibition and Oxidative Stress in Mouse Thymus Cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26443841 DOI: 10.1093/toxsci/kfv211  1
2015 Guo Y, Kenney SR, Muller CY, Adams S, Rutledge T, Romero E, Murray-Krezan C, Prekeris R, Sklar LA, Hudson LG, Wandinger-Ness A. R-ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis. Molecular Cancer Therapeutics. PMID 26206334 DOI: 10.1158/1535-7163.MCT-15-0419  1
2015 Guo Y, Kenney SR, Cook LS, Adams SF, Rutledge T, Romero E, Oprea T, Sklar LA, Bedrick E, Wiggins CL, Kang H, Lomo L, Muller CY, Wandinger-Ness A, Hudson LG. A novel pharmacologic activity of ketorolac for therapeutic benefit in ovarian cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26071482 DOI: 10.1158/1078-0432.CCR-15-0461  1
2015 Zhou X, Cooper KL, Sun X, Liu KJ, Hudson LG. Selective Sensitization of Zinc Finger Protein Oxidation by Reactive Oxygen Species through Arsenic Binding. The Journal of Biological Chemistry. 290: 18361-9. PMID 26063799 DOI: 10.1074/jbc.M115.663906  1
2015 Zhou X, Burchiel SW, Hudson LG, Liu KJ. Conference Summary and Recent Advances: the 8th Conference on Metal Toxicity and Carcinogenesis. Biological Trace Element Research. 166: 1-6. PMID 25975949 DOI: 10.1007/s12011-015-0363-y  0.44
2015 Ezeh PC, Lauer FT, Liu KJ, Hudson LG, Burchiel SW. Arsenite Interacts with Dibenzo[def,p]chrysene (DBC) at Low Levels to Suppress Bone Marrow Lymphoid Progenitors in Mice. Biological Trace Element Research. 166: 82-8. PMID 25739538 DOI: 10.1007/s12011-015-0279-6  0.44
2014 Burchiel SW, Lauer FT, Beswick EJ, Gandolfi AJ, Parvez F, Liu KJ, Hudson LG. Differential susceptibility of human peripheral blood T cells to suppression by environmental levels of sodium arsenite and monomethylarsonous acid. Plos One. 9: e109192. PMID 25271956 DOI: 10.1371/journal.pone.0109192  1
2014 Ezeh PC, Lauer FT, MacKenzie D, McClain S, Liu KJ, Hudson LG, Gandolfi AJ, Burchiel SW. Arsenite selectively inhibits mouse bone marrow lymphoid progenitor cell development in vivo and in vitro and suppresses humoral immunity in vivo. Plos One. 9: e93920. PMID 24714590 DOI: 10.1371/journal.pone.0093920  0.44
2014 Zhou X, Sun X, Mobarak C, Gandolfi AJ, Burchiel SW, Hudson LG, Liu KJ. Differential binding of monomethylarsonous acid compared to arsenite and arsenic trioxide with zinc finger peptides and proteins. Chemical Research in Toxicology. 27: 690-8. PMID 24611629 DOI: 10.1021/tx500022j  0.44
2014 Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 274: 313-8. PMID 24275069 DOI: 10.1016/j.taap.2013.11.010  0.44
2013 Cooper KL, King BS, Sandoval MM, Liu KJ, Hudson LG. Reduction of arsenite-enhanced ultraviolet radiation-induced DNA damage by supplemental zinc. Toxicology and Applied Pharmacology. 269: 81-8. PMID 23523584 DOI: 10.1016/j.taap.2013.03.008  1
2013 Hong L, Kenney SR, Phillips GK, Simpson D, Schroeder CE, Nöth J, Romero E, Swanson S, Waller A, Strouse JJ, Carter M, Chigaev A, Ursu O, Oprea T, Hjelle B, ... ... Hudson LG, et al. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. The Journal of Biological Chemistry. 288: 8531-43. PMID 23382385 DOI: 10.1074/jbc.M112.435941  1
2012 King BS, Cooper KL, Liu KJ, Hudson LG. Poly(ADP-ribose) contributes to an association between poly(ADP-ribose) polymerase-1 and xeroderma pigmentosum complementation group A in nucleotide excision repair. The Journal of Biological Chemistry. 287: 39824-33. PMID 23038248 DOI: 10.1074/jbc.M112.393504  1
2012 Qin XJ, Liu W, Li YN, Sun X, Hai CX, Hudson LG, Liu KJ. Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicological Sciences : An Official Journal of the Society of Toxicology. 127: 120-9. PMID 22387748 DOI: 10.1093/toxsci/kfs099  1
2012 Chavez MG, Buhr CA, Petrie WK, Wandinger-Ness A, Kusewitt DF, Hudson LG. Differential downregulation of e-cadherin and desmoglein by epidermal growth factor. Dermatology Research and Practice. 2012: 309587. PMID 22312325 DOI: 10.1155/2012/309587  1
2011 Zhou X, Sun X, Cooper KL, Wang F, Liu KJ, Hudson LG. Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs. The Journal of Biological Chemistry. 286: 22855-63. PMID 21550982 DOI: 10.1074/jbc.M111.232926  1
2011 Burkhalter RJ, Symowicz J, Hudson LG, Gottardi CJ, Stack MS. Integrin regulation of beta-catenin signaling in ovarian carcinoma. The Journal of Biological Chemistry. 286: 23467-75. PMID 21518759 DOI: 10.1074/jbc.M110.199539  1
2010 Burchiel SW, Mitchell LA, Lauer FT, Sun X, McDonald JD, Hudson LG, Liu KJ. Corrigendum to "Immunotoxicity and biodistribution analysis of arsenic trioxide in C57B1/6 mice following a 2-week inhalation exposure": [Toxicol. Appl. Pharmacol. 241 (2009) 253-259]. Toxicology and Applied Pharmacology. 246: 188. PMID 21103386 DOI: 10.1016/j.taap.2010.05.001  0.44
2010 Hudson LG, Gale JM, Padilla RS, Pickett G, Alexander BE, Wang J, Kusewitt DF. Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes. Molecular Carcinogenesis. 49: 619-29. PMID 20564339 DOI: 10.1002/mc.20636  1
2010 Li Q, Lauer FT, Liu KJ, Hudson LG, Burchiel SW. Low-dose synergistic immunosuppression of T-dependent antibody responses by polycyclic aromatic hydrocarbons and arsenic in C57BL/6J murine spleen cells. Toxicology and Applied Pharmacology. 245: 344-51. PMID 20353797 DOI: 10.1016/j.taap.2010.03.020  0.44
2010 Zeineldin R, Ning Y, Hudson LG. The constitutive activity of epidermal growth factor receptor vIII leads to activation and differential trafficking of wild-type epidermal growth factor receptor and erbB2. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 58: 529-41. PMID 20159766 DOI: 10.1369/jhc.2010.955104  0.6
2010 Zeineldin R, Muller CY, Stack MS, Hudson LG. Targeting the EGF receptor for ovarian cancer therapy. Journal of Oncology. 2010: 414676. PMID 20066160 DOI: 10.1155/2010/414676  0.6
2009 Burchiel SW, Mitchell LA, Lauer FT, Sun X, McDonald JD, Hudson LG, Liu KJ. Immunotoxicity and biodistribution analysis of arsenic trioxide in C57Bl/6 mice following a 2-week inhalation exposure. Toxicology and Applied Pharmacology. 241: 253-9. PMID 19800901 DOI: 10.1016/j.taap.2009.09.019  1
2009 Barbolina MV, Moss NM, Westfall SD, Liu Y, Burkhalter RJ, Marga F, Forgacs G, Hudson LG, Stack MS. Microenvironmental regulation of ovarian cancer metastasis. Cancer Treatment and Research. 149: 319-34. PMID 19763443 DOI: 10.1007/978-0-387-98094-2_15  1
2009 Hudson LG, Zeineldin R, Silberberg M, Stack MS. Activated epidermal growth factor receptor in ovarian cancer. Cancer Treatment and Research. 149: 203-26. PMID 19763438 DOI: 10.1007/978-0-387-98094-2_10  1
2009 Hudson LG, Newkirk KM, Chandler HL, Choi C, Fossey SL, Parent AE, Kusewitt DF. Cutaneous wound reepithelialization is compromised in mice lacking functional Slug (Snai2). Journal of Dermatological Science. 56: 19-26. PMID 19643582 DOI: 10.1016/j.jdermsci.2009.06.009  1
2009 Moss NM, Liu Y, Johnson JJ, Debiase P, Jones J, Hudson LG, Munshi HG, Stack MS. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen. Molecular Cancer Research : McR. 7: 809-20. PMID 19509114 DOI: 10.1158/1541-7786.MCR-08-0571  1
2009 Cooper KL, Liu KJ, Hudson LG. Enhanced ROS production and redox signaling with combined arsenite and UVA exposure: contribution of NADPH oxidase. Free Radical Biology & Medicine. 47: 381-8. PMID 19414066 DOI: 10.1016/j.freeradbiomed.2009.04.034  1
2009 Hudson LG, Moss NM, Stack MS. EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma. Future Oncology (London, England). 5: 323-38. PMID 19374540 DOI: 10.2217/fon.09.10  1
2009 Sun X, Pi J, Liu W, Hudson LG, Liu KJ, Feng C. Induction of heme oxygenase 1 by arsenite inhibits cytokine-induced monocyte adhesion to human endothelial cells. Toxicology and Applied Pharmacology. 236: 202-9. PMID 19371606 DOI: 10.1016/j.taap.2009.01.023  0.44
2009 Zeineldin R, Al-Haik M, Hudson LG. Role of polyethylene glycol integrity in specific receptor targeting of carbon nanotubes to cancer cells. Nano Letters. 9: 751-7. PMID 19152309 DOI: 10.1021/nl8033174  0.6
2009 Ding W, Liu W, Cooper KL, Qin XJ, de Souza Bergo PL, Hudson LG, Liu KJ. Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage. The Journal of Biological Chemistry. 284: 6809-17. PMID 19056730 DOI: 10.1074/jbc.M805566200  1
2009 Kusewitt DF, Choi C, Newkirk KM, Leroy P, Li Y, Chavez MG, Hudson LG. Slug/Snai2 is a downstream mediator of epidermal growth factor receptor-stimulated reepithelialization. The Journal of Investigative Dermatology. 129: 491-5. PMID 18685621 DOI: 10.1038/jid.2008.222  1
2008 Qin XJ, Hudson LG, Liu W, Ding W, Cooper KL, Liu KJ. Dual actions involved in arsenite-induced oxidative DNA damage. Chemical Research in Toxicology. 21: 1806-13. PMID 18707137 DOI: 10.1021/tx8001548  1
2008 Ding W, Hudson LG, Sun X, Feng C, Liu KJ. As(III) inhibits ultraviolet radiation-induced cyclobutane pyrimidine dimer repair via generation of nitric oxide in human keratinocytes. Free Radical Biology & Medicine. 45: 1065-72. PMID 18621123 DOI: 10.1016/j.freeradbiomed.2008.06.022  0.44
2008 Qin XJ, Hudson LG, Liu W, Timmins GS, Liu KJ. Low concentration of arsenite exacerbates UVR-induced DNA strand breaks by inhibiting PARP-1 activity. Toxicology and Applied Pharmacology. 232: 41-50. PMID 18619636 DOI: 10.1016/j.taap.2008.05.019  0.44
2008 Cowden Dahl KD, Symowicz J, Ning Y, Gutierrez E, Fishman DA, Adley BP, Stack MS, Hudson LG. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Research. 68: 4606-13. PMID 18559505 DOI: 10.1158/0008-5472.CAN-07-5046  1
2008 Hudson LG, Zeineldin R, Stack MS. Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clinical & Experimental Metastasis. 25: 643-55. PMID 18398687 DOI: 10.1007/s10585-008-9171-5  1
2007 Cowden Dahl KD, Zeineldin R, Hudson LG. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells. Molecular Cancer Research : McR. 5: 413-21. PMID 17475671 DOI: 10.1158/1541-7786.MCR-07-0019  0.6
2007 Symowicz J, Adley BP, Gleason KJ, Johnson JJ, Ghosh S, Fishman DA, Hudson LG, Stack MS. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Research. 67: 2030-9. PMID 17332331 DOI: 10.1158/0008-5472.CAN-06-2808  1
2007 Hudson LG, Choi C, Newkirk KM, Parkhani J, Cooper KL, Lu P, Kusewitt DF. Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes. Molecular Carcinogenesis. 46: 257-68. PMID 17295233 DOI: 10.1002/mc.20257  1
2007 Cooper KL, Liu KJ, Hudson LG. Contributions of reactive oxygen species and mitogen-activated protein kinase signaling in arsenite-stimulated hemeoxygenase-1 production. Toxicology and Applied Pharmacology. 218: 119-27. PMID 17196236 DOI: 10.1016/j.taap.2006.09.020  1
2007 Ning Y, Buranda T, Hudson LG. Activated epidermal growth factor receptor induces integrin alpha2 internalization via caveolae/raft-dependent endocytic pathway. The Journal of Biological Chemistry. 282: 6380-7. PMID 17179151 DOI: 10.1074/jbc.M610915200  0.6
2006 Zeineldin R, Rosenberg M, Ortega D, Buhr C, Chavez MG, Stack MS, Kusewitt DF, Hudson LG. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III. Molecular Carcinogenesis. 45: 851-60. PMID 16788982 DOI: 10.1002/mc.20237  1
2006 Zeineldin R, Hudson LG. Epithelial cell migration in response to epidermal growth factor. Methods in Molecular Biology (Clifton, N.J.). 327: 147-58. PMID 16780219 DOI: 10.1385/1-59745-012-X:147  0.6
2005 Ding W, Hudson LG, Liu KJ. Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Molecular and Cellular Biochemistry. 279: 105-12. PMID 16283519 DOI: 10.1007/s11010-005-8227-y  0.44
2005 Ning Y, Zeineldin R, Liu Y, Rosenberg M, Stack MS, Hudson LG. Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation. Cancer Research. 65: 9280-6. PMID 16230389 DOI: 10.1158/0008-5472.CAN-05-0407  1
2005 Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Research. 65: 2234-42. PMID 15781636 DOI: 10.1158/0008.5472.CAN-04-2781  1
2004 Cooper KL, Myers TA, Rosenberg M, Chavez M, Hudson LG. Roles of mitogen activated protein kinases and EGF receptor in arsenite-stimulated matrix metalloproteinase-9 production. Toxicology and Applied Pharmacology. 200: 177-85. PMID 15504454 DOI: 10.1016/j.taap.2004.04.023  1
2004 Shi H, Hudson LG, Liu KJ. Oxidative stress and apoptosis in metal ion-induced carcinogenesis. Free Radical Biology & Medicine. 37: 582-93. PMID 15288116 DOI: 10.1016/j.freeradbiomed.2004.03.012  0.44
2004 Shi H, Hudson LG, Ding W, Wang S, Cooper KL, Liu S, Chen Y, Shi X, Liu KJ. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chemical Research in Toxicology. 17: 871-8. PMID 15257611 DOI: 10.1021/tx049939e  1
2003 Burdick AD, Davis JW, Liu KJ, Hudson LG, Shi H, Monske ML, Burchiel SW. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Research. 63: 7825-33. PMID 14633709  0.44
1993 Xu J, Thompson KL, Shephard LB, Hudson LG, Gill GN. T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites. The Journal of Biological Chemistry. 268: 16065-73. PMID 8393457  1
1991 Hudson LG, Gill GN. Regulation of gene expression by epidermal growth factor. Genetic Engineering. 13: 137-51. PMID 1367411  1
1990 Hudson LG, Thompson KL, Xu J, Gill GN. Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. Proceedings of the National Academy of Sciences of the United States of America. 87: 7536-40. PMID 2170982  1
1990 Hudson LG, Santon JB, Glass CK, Gill GN. Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell. 62: 1165-75. PMID 2169350  1
1990 Hudson LG, Ertl AP, Gill GN. Structure and inducible regulation of the human c-erb B2/neu promoter. The Journal of Biological Chemistry. 265: 4389-93. PMID 1968458  1
1989 Hudson LG, Santon JB, Gill GN. Regulation of epidermal growth factor receptor gene expression. Molecular Endocrinology (Baltimore, Md.). 3: 400-8. PMID 2540431 DOI: 10.1210/mend-3-2-400  1
1987 Walton GM, Bertics PJ, Hudson LG, Vedvick TS, Gill GN. A three-step purification procedure for protein kinase C: Characterization of the purified enzyme Analytical Biochemistry. 161: 425-437. PMID 3472471 DOI: 10.1016/0003-2697(87)90471-4  1
1986 Hudson LG, Toscano WA, Greenlee WF. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF) binding to basal cells from a human keratinocyte cell line. Toxicology and Applied Pharmacology. 82: 481-92. PMID 3952731  1
1985 Greenlee WF, Osborne R, Dold KM, Hudson LG, Toscano WA. Toxicity of chlorinated aromatic compounds in animals and humans: in vitro approaches to toxic mechanisms and risk assessment. Environmental Health Perspectives. 60: 69-76. PMID 2992929  1
1985 Hudson LG, Toscano WA, Greenlee WF. Regulation of epidermal growth factor binding in a human keratinocyte cell line by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology. 77: 251-9. PMID 2579474  1
1983 Hudson LG, Shaikh R, Toscano WA, Greenlee WF. Induction of 7-ethoxycoumarin o-deethylase activity in cultured human epithelial cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): evidence for TCDD receptor. Biochemical and Biophysical Research Communications. 115: 611-7. PMID 6312985  1
Show low-probability matches.